Silver aids healing in the sterile skin wound: Experimental studies in the laboratory rat

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 728-735

  Lansdown, A B G ^a   Sampson, B ^a   Laupattarakasem, P ^b   Vuttivirojana, A ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

METAL ION; METALLOTHIONEIN; SILVER; SILVER NITRATE; SULFADIAZINE SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GRANULATION TISSUE; HAIR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INCISION; SKIN INFLAMMATION; SKIN INJURY; TOPICAL DRUG ADMINISTRATION; WOUND CLOSURE; WOUND HEALING;

EID: 0030659136     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01109.x     Document Type: Article

References (46)

1. Cotzias GC. In: Mineral Metabolism (Comar CL, Bonner J, eds). New York: Academic Press, 1962: 403.
2. Lansdown ABG. Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit Rev Toxicol 1995; 25: 397-462.
3. Moyer CA, Brentano L, Gravens DL et al. Treatment of large human burns with 0-5% silver nitrate solutions. Arch Surg 1965; 90: 812-67.
4. Fox CL. Silver sulphadiazine - a new topical therapy for Pseudomonas in burns. Arch Surg 1977; 96: 184-8.
5. Lowbury EJL, Babb JR, Bridges K. Jackson DM. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant gram-negative bacilli. Br Med J 1976; 1: 493-6.
6. Groeger JS, Lucas AB, Coit D et al. A prospective randomised evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunnelled chronic venous access catheter infections in cancer patients. Ann Surg 1993; 218: 206-10.
7. Solleman T. Silver. In: A Manual of Pharmacology Philadelphia, PA: WB Saunders Co., 1942; 1102-9.
8. Margraf HW, Covey TR. A trial of silver-zinc-allantoinate in the treatment of leg ulcers. Arch Surg 1977; 112: 699-704.
9. Chu CS, McManus AT, Pruitt BA, Mason AD. Therapeutic effect of silver nylon dressings with weak direct current on Pseudomonas aeruginosa-infected burn. J Trauma 1988; 28: 1488-92.
10. Ersek RA, Navarro JA. Maximising wound healing with silver impregnated porcine xenograft. Today's OP-Nurse 1990; 12: 4-9.
11. Kjolseth D, Frank JM, Barker JH et al. Comparison of the effects of commonly used wound agents on epithelialisation and neovascularisation. J Am Coll Surg 1994; 179: 305-12.
12. Stern HS. Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial. Br J Plast Surg 1989; 42: 581-5.
13. Hunt TH. Iodine and wound physiology. In: Proceedings of the 5th Annual Meeting, European Tissue Repair Society, Padua, Italy, 1995; 2.1-2.6.
14. Mertz P. Iodine and wound physiology. In: Proceedings of the 5th Annual Meeting, European Tissue Repair Society, Padua, Italy, 1995; 2.6.
15. Lansdown ABG. Production of epidermal damage in mammalian skin by some simple aluminium compunds. Br J Dermatol 1973; 89: 67-76.
16. Lansdown ABG. Interspecies variations in response to topical application of selected zinc compunds. Fd Chem Toxicol 1991; 29: 57-64.
17. Lansdown ABG. Influence of zinc oxide on the closure of open wounds: an experimental study. Int J Cosmet Sci 1993; 15: 83-5.
18. Lansdown ABG, Pate P. Animal models in wound healing in the skin. In: Proceedings of the 5th Annual Symposium of the Federation of European Laboratory Animal Associations, Brighton, U.K., 1993; 395-6.
19. Lansdown ABG, Sampson B. Dermal toxicity and percutaneous absorption of cadmium in rats and mice. Lab Anim Sci 1996; 46: 549-54.
20. Flecknall P. In: Laboratory Animal Anaesthesia. 2nd edn. London: Academic Press, 1996.
21. Bleehen SS, Gould DJ, Harrington CI et al. Occupational argyria: light and electron microscopic studies and X-ray microanalysis. Br J Dermatol 1981; 104: 19-26.
22. Hoekstra MJ, Hupkens P, Dutrieux RP et al. A comparative burn wound model in the New Yorkshire pig for the histopathological evaluation of local therapeutic regimens: silver sulphadiazine cream as a standard. Br J Plast Surg 1993; 46: 585-9.
23. Roe EA, Jones RJ. Leukocyte responses in burned mice given gram-negative infections and treated topically with creams containing silver compounds. Burns 1977; 3: 72-9.
24. Caffee H, Bingham HG. Leukopenia and silver sulphadiazine. J Trauma 1982; 22: 586-7.
25. Coombs CJ, Wan AT, Masterton JP et al. Do burn patients have a silver lining? Burns 1992; 18: 179-84.
26. Buckley WR. Localised argyria. Arch Dermatol 1963; 88: 531-9.
27. Pariser RJ. Generalised argyria. Arch Dermatol 1968; 114: 373-7.
28. East BW, Boddy K, Williams ED et al. Silver retention, total body silver and tissue silver concentrations, argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin Exp Dermatol 1980; 5: 305-11.
29. Buckley WR, Oster CF, Fassett DW. Localised argyria: chemical nature of the silver containing granules. Arch Dermatol 1965; 92: 697-705.
30. Marshall IP, Schneider RP. Systemic argyria secondary to topical silver nitrate. Arch Dermatol 1977; 113: 1077-9.
31. Buckley WR, Terhaar DJ. The skin as an excretory organ in argyria. Trans St John's Hosp Dermatol Soc 1973; 59: 39-44.
32. Dupuis LL, Shear NH, Zuker RM. Hyperpigmentation due to topical application of silver sulphadiazine cream. J Am Acad Dermatol 1985; 12: 1112-14.
33. Grabowski BF, Haney WG. Characterisation of silver deposits in tissue resulting from dermal application of a silver containing pharmaceutical. J Pharm Sci 1972; 61: 1488-90.
34. Wysor MS. Orally administered silver sulphadiazine: chemotherapy and toxicology in CF-1 mice. Plasmodium berghei (malaria) and Pseduomonas aeruginosa. Chemotherapy 1975; 21: 302-10.
35. Cook DS, Turner MF. Crystal and molecular structures of silver sulphadiazine (N-pyrimidin-2-yl sulphanilamide). J Chem Soc 1975; 11: 1021-5.
36. Fox CL. Pharmacodynamics of silver sulphadiazine and related topical antimicrobial agents. In: Recent Advances in Dermatopharmacology (Frost P, Gomez EC, Zaias N, eds). New York: Spectrum, 1977: 441-56.
37. Harrison HN. Pharmacology of sulphadiazine silver. Arch Surg 1979; 114: 281-5.
38. Wang X, Wang NZ, Zhang OZ et al. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. Burns 1985; 11: 197-201.
39. Fox CL, Modal SM. Mechanism of silver sulphadiazine action on burn wound infections. Antimicrobial Agents and Chemotherapy 1974; 5: 582-8.
40. Akahane T, Tsukada S. Electronmicroscopic observation on silver deposition in burn wounds treated with silver sulphadiazine cream. Burns 1982; 8: 271-3.
41. Henzel JH, DeWeese MS, Lichti EL. Zinc concentrations within healing wounds. Arch Surg 1970; 100: 349-57.
42. Lansdown ABG. Zinc in the healing wound. Lancet 1996; 347: 706-7.
43. Winge DR, Nielson KB. Distinct metal binding configurations in metallothionein. In: Trace Elements in Man and Animals (Mills CF, Bremner I, Chesters JK, eds). Slough: CAB, 1985; 307-11.
44. Heng MK, Song MK, Heng MCY. Reciprocity between tissue calmodulin and cAMP levels: modulation by excess zinc. Br J Dermatol 1993; 129: 280-5.
45. Hennings H, Michael D, Cheng C. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 1980; 19: 245-54.
46. Yuspa SM, Kilkenny AE, Steinert PM et al. Expression of murine epidermal cell markers is tightly regulated by extracellular calcium concentrations in vitro. J Cell Biol 1989; 109: 1207-17.